AVDL
Avadel Pharmaceuticals
AVDL
AVDL
99 hedge funds and large institutions have $559M invested in Avadel Pharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 35 increasing their positions, 26 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
14% less funds holding in top 10
Funds holding in top 10: 7 → 6 (-1)
23.25% less ownership
Funds ownership: 84.1% → 60.85% (-23%)
35% less capital invested
Capital invested by funds: $856M → $559M (-$297M)
Holders
99
Holding in Top 10
6
Calls
$11M
Puts
$3.37M
Top Buyers
| 1 | +$32.1M | |
| 2 | +$10.3M | |
| 3 | +$3.36M | |
| 4 |
MB
MPM BioImpact
Boston,
Massachusetts
|
+$2.88M |
| 5 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
+$2.77M |
Top Sellers
| 1 | -$11.1M | |
| 2 | -$9.84M | |
| 3 | -$8.24M | |
| 4 |
PCM
Portolan Capital Management
Boston,
Massachusetts
|
-$4.78M |
| 5 |
CAC
Cowen and Company
New York
|
-$3.36M |